Ocular Therapeutix (OCUL) Cash from Financing Activities (2013 - 2026)
Ocular Therapeutix (OCUL) posted Cash from Financing Activities of $2.58 million for Q2 2026, down 97.4% from $97.81 million a year earlier but up 777.9% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Cash from Financing Activities (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Ocular Therapeutix was $462.61 million, up 318.0% year-over-year; for FY2025, it came in at $561.72 million, up 69.1% from FY2024.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of 19.8% (FY2020 to FY2025).
- In prior years, Ocular Therapeutix's Cash from Financing Activities was $332.11 million in FY2024 (+95.6%), $169.83 million in FY2023, $1.45 million in FY2022 (-49.0%) and $2.85 million in FY2021 (-98.7%).
- Quarterly Cash from Financing Activities has run from a low of $78,000 in Q1 2023 to a high of $449.38 million in Q4 2025 over five years.
- On a year-over-year basis, Cash from Financing Activities increased in 1 of the last six quarters, with an average decline of 54.8%.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q3 2021, with growth of 208.6%; the weakest was Q4 2021, with a decline of 99.6%.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $294,000 (Q1 2026), $449.38 million (Q4 2025) and $10.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.58 Mn |
| Mar 31, 2026 | 294,000.00 |
| Dec 31, 2025 | 449.38 Mn |
| Sep 30, 2025 | 10.36 Mn |
| Jun 30, 2025 | 97.81 Mn |
| Mar 31, 2025 | 4.18 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Sep 30, 2024 | 4.18 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 321.22 Mn |
| Dec 31, 2023 | 108.17 Mn |
| Sep 30, 2023 | 51.94 Mn |
| Jun 30, 2023 | 9.65 Mn |
| Mar 31, 2023 | 78,000.00 |
| Dec 31, 2022 | 458,000.00 |
| Sep 30, 2022 | 374,000.00 |
| Jun 30, 2022 | 493,000.00 |
| Mar 31, 2022 | 129,000.00 |
| Dec 31, 2021 | 667,000.00 |
| Sep 30, 2021 | 679,000.00 |
API Access
Ocular Therapeutix Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();